Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1202771014 | Guaifenesin + theophylline, anhydrous 90mg/150mg liquid (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1478810013 | Guaifenesin+theophylline, anhydrous 90mg/150mg liquid | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3147911000052112 | guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Is a | Product containing theophylline (medicinal product) | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Is a | Expectorant agent | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Is a | Product containing guaifenesin (medicinal product) | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Is a | Theophylline-containing product in oral dose form | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has active ingredient | Theophylline (substance) | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has active ingredient | Smooth muscle relaxant (substance) | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has active ingredient | Guaifenesin | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Is a | Product containing guaifenesin and theophylline (medicinal product) | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has active ingredient | Theophylline anhydrous | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has manufactured dose form | oral vätska | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has active ingredient | Xanthine | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Has active ingredient | medel för behandling av muskuloskeletala systemet | false | Inferred relationship | Some | ||
guajfenesin 90 mg + teofyllin 150 mg, vattenfritt, vätska | Is a | Theophylline-containing product in oral dose form | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set